More commonly, however, constitutive NF-κB activation in cancer ensues from inflammatory stimuli and other cues emanating from the TME or oncogenic alterations lying outside the traditional NF-κB pathway, such as RAS and PTEN mutations. This evidence concerns the gene NFKB1 and cancer.